| Canagliflozin and cardiovascular and renal events in type 2 diabetes B Neal, V Perkovic, KW Mahaffey, D De Zeeuw, G Fulcher, N Erondu, ... New England Journal of Medicine 377 (7), 644-657, 2017 | 8379 | 2017 |
| Canagliflozin and renal outcomes in type 2 diabetes and nephropathy V Perkovic, MJ Jardine, B Neal, S Bompoint, HJL Heerspink, ... New England journal of medicine 380 (24), 2295-2306, 2019 | 5600 | 2019 |
| Dapagliflozin in patients with chronic kidney disease HJL Heerspink, BV Stefánsson, R Correa-Rotter, GM Chertow, T Greene, ... New England Journal of Medicine 383 (15), 1436-1446, 2020 | 4239 | 2020 |
| Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes JB Green, MA Bethel, PW Armstrong, JB Buse, SS Engel, J Garg, R Josse, ... New England Journal of Medicine 373 (3), 232-242, 2015 | 3246 | 2015 |
| Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes RR Holman, MA Bethel, RJ Mentz, VP Thompson, Y Lokhnygina, JB Buse, ... New England Journal of Medicine 377 (13), 1228-1239, 2017 | 2123 | 2017 |
| Benefits of polyphenols on gut microbiota and implications in human health F Cardona, C Andrés-Lacueva, S Tulipani, FJ Tinahones, ... The Journal of nutritional biochemistry 24 (8), 1415-1422, 2013 | 1732 | 2013 |
| Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes M Husain, AL Birkenfeld, M Donsmark, K Dungan, FG Eliaschewitz, ... New England Journal of Medicine 381 (9), 841-851, 2019 | 1589 | 2019 |
| Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial AF Hernandez, JB Green, S Janmohamed, RB D'Agostino, CB Granger, ... The Lancet 392 (10157), 1519-1529, 2018 | 1484 | 2018 |
| Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects WPT James, ID Caterson, W Coutinho, N Finer, LF Van Gaal, ... New England Journal of Medicine 363 (10), 905-917, 2010 | 1227 | 2010 |
| Effect of linagliptin vs placebo on major cardiovascular events in adults with type 2 diabetes and high cardiovascular and renal risk: the CARMELINA randomized clinical trial J Rosenstock, V Perkovic, OE Johansen, ME Cooper, SE Kahn, N Marx, ... Jama 321 (1), 69-79, 2019 | 1173 | 2019 |
| Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance JM Moreno-Navarrete, F Ortega, M Serrano, E Guerra, G Pardo, ... The journal of clinical endocrinology & metabolism 98 (4), E769-E778, 2013 | 995 | 2013 |
| Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study M Murri, I Leiva, JM Gomez-Zumaquero, FJ Tinahones, F Cardona, ... BMC medicine 11, 1-12, 2013 | 918 | 2013 |
| Influence of red wine polyphenols and ethanol on the gut microbiota ecology and biochemical biomarkers MI Queipo-Ortuño, M Boto-Ordóñez, M Murri, JM Gomez-Zumaquero, ... The American journal of clinical nutrition 95 (6), 1323-1334, 2012 | 795 | 2012 |
| Efficacy and safety of degludec versus glargine in type 2 diabetes SP Marso, DK McGuire, B Zinman, NR Poulter, SS Emerson, TR Pieber, ... New England Journal of Medicine 377 (8), 723-732, 2017 | 715 | 2017 |
| Cardiovascular efficacy and safety of bococizumab in high-risk patients PM Ridker, J Revkin, P Amarenco, R Brunell, M Curto, F Civeira, ... New England Journal of Medicine 376 (16), 1527-1539, 2017 | 694 | 2017 |
| EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study KK Ray, B Molemans, WM Schoonen, P Giovas, S Bray, G Kiru, J Murphy, ... European journal of preventive cardiology 28 (11), 1279-1289, 2021 | 665 | 2021 |
| Gut microbiota composition in male rat models under different nutritional status and physical activity and its association with serum leptin and ghrelin levels MI Queipo-Ortuño, LM Seoane, M Murri, M Pardo, JM Gomez-Zumaquero, ... PloS one 8 (5), e65465, 2013 | 597 | 2013 |
| Mirror extreme BMI phenotypes associated with gene dosage at the chromosome 16p11. 2 locus S Jacquemont, A Reymond, F Zufferey, L Harewood, RG Walters, ... Nature 478 (7367), 97-102, 2011 | 549 | 2011 |
| Lifestyle recommendations for the prevention and management of metabolic syndrome: an international panel recommendation P Pérez-Martínez, DP Mikhailidis, VG Athyros, M Bullo, P Couture, ... Nutrition reviews 75 (5), 307-326, 2017 | 461 | 2017 |
| Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial S Del Prato, SE Kahn, I Pavo, GJ Weerakkody, Z Yang, J Doupis, ... The Lancet 398 (10313), 1811-1824, 2021 | 451 | 2021 |